SK life science Presents Long-term Data on Cognitive and Psychiatric Adverse Events Associated with XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AAN 2022 Annual Meeting
First in-depth, 5-year analysis of cognitive and psychiatric antagonistic occasions related to cenobamate in grownup sufferers with uncontrolled partial-onset (focal) ...
